Optimizing Management of Chronic GVHD: The Care Team’s Role in Symptom Management and Patient Care : Episode 4
Early Symptom Detection and the Impact on Patient Outcomes in GVHD
Panelists discuss how the care team identifies and manages symptoms in chronic graft-versus-host disease patients, particularly those with advanced disease, emphasizing key symptoms to monitor, approaches to symptom identification, and the critical importance of early detection and management for improving patient outcomes.
Video content above is prompted by the following:
- Now, let's focus on the crucial role that the care team plays in identifying and managing symptoms for cGVHD patients, particularly those with advanced disease.
- What are the key symptoms you look for when assessing cGVHD patients? How do you approach symptom identification, especially for those with advanced disease?
- Can you explain the importance of early symptom identification and management in cGVHD? How does this affect patient outcomes?
Recent Videos
Related Content
BLA Resubmission Accepted by the FDA for Remestemcel-L in Pediatric Steroid-Refractory aGVHD
August 11th 2024Article
The biologics license application that was resubmitted for remestemcel-L has been accepted by the FDA for the potential treatment of children with steroid-refractory acute graft-vs-host-disease.
